Inactive Instrument
Abpro Corporation Share Price Nasdaq
Stocks
US0008501076
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 23.58L 20.57L 19.42L 17.63L 33.04L 23Cr 33.18L 2.33Cr 89.76L 12Cr 88.59L 86.63L 37Cr | P/E 2024 |
-2.41x | P/E 2025 | -3.27x |
|---|---|---|---|---|---|
| Enterprise Value | 24.38L 21.26L 20.08L 18.23L 34.16L 23Cr 34.3L 2.4Cr 92.81L 12Cr 91.6L 89.57L 38Cr | EV / Sales 2024 |
497x | EV / Sales 2025 | - |
| Free-Float |
83.91% | Yield 2024 * |
-
| Yield 2025 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 23.58L | |
| +0.11% | +2.71% | +0.33% | +28.59% | 4.62TCr | |
| -0.86% | +1.43% | +39.60% | +26.83% | 4.43TCr | |
| -4.01% | -6.61% | +320.81% | +515.23% | 4.22TCr | |
| -1.03% | +1.14% | +2.21% | +67.76% | 4.02TCr | |
| -0.50% | -0.77% | +11.86% | +40.41% | 2.98TCr | |
| -0.38% | +4.04% | +21.77% | +123.81% | 1.72TCr | |
| -0.82% | -9.45% | - | - | 1.57TCr | |
| -0.57% | +8.12% | +22.15% | +38.93% | 1.53TCr | |
| -2.96% | -3.60% | -9.04% | -37.95% | 1.31TCr | |
| Average | -1.14% | +1.67% | +51.21% | +100.45% | 2.93TCr | |
| Weighted average by Cap. | -1.28% | +1.63% | +65.84% | +122.47% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2L 2L 2L 1L 3L 1.76Cr 3L 18.05L 7L 89.28L 7L 7L 2.87Cr | - |
| Net income | -72.32L -63.06L -59.55L -54.07L -1.01Cr -69Cr -1.02Cr -7.13Cr -2.75Cr -35Cr -2.72Cr -2.66Cr -113.52Cr | -28.92L -25.22L -23.81L -21.62L -40.51L -28Cr -40.68L -2.85Cr -1.1Cr -14Cr -1.09Cr -1.06Cr -45Cr |
| Net Debt | 5L 4L 4L 4L 7L 4.59Cr 7L 47.14L 18.19L 2.33Cr 17.96L 17.56L 7.5Cr | 80T 69.76T 65.87T 59.81T 1L 76.76L 1L 8L 3L 39.03L 3L 3L 1.26Cr |
Employees
-
